ZURICH, Oct 16 (Reuters) - Switzerland signed a contract for
up to 5.3 million doses of a potential COVID-19 vaccine being
developed and tested by AstraZeneca and Oxford
University, the Swiss government said https://www.admin.ch/gov/en/start/documentation/media-releases.msg-id-80732.html
on Friday.
"The Swiss federal government wants to assure members of the
Swiss public rapid access to COVID-19 vaccines," it said in a
statement. "Given that it is still not clear which vaccines will
ultimately prevail, the government is taking a diversified
approach. It has now signed an agreement with UK pharmaceuticals
company AstraZeneca and the Swedish government for the delivery
of up to 5.3 million doses of vaccine."
The contract is based on an agreement between the European
Commission and AstraZeneca for the delivery of up to 400 million
doses for Europe, it added.
(Reporting by John Miller; Editing by Michael Shields)
Astrazeneca (AZN)
